Market Research Report
North America Clinical Nutrition Market Forecast 2019-2028
|Published by||Inkwood Research||Product code||952509|
|Published||Content info||114 Pages
Delivery time: 2-3 business days
|North America Clinical Nutrition Market Forecast 2019-2028|
|Published: August 3, 2020||Content info: 114 Pages||
The North America clinical nutrition market is projected to evolve at a CAGR of 5.27% during the forecast period, 2019-2028. The continuous R&D activities, with regard to the development of innovative clinical nutrition, and the growing incidences of ischemic stroke, diabetes, coronary artery disease, etc. are set to drive the market growth.
The North America clinical nutrition market growth analysis entails the assessment of Canada and the United States. Preventive medical nutrition is being increasingly adopted by hospitals and clinics in North America. The coverage of universal healthcare in Canada is far more extensive in comparison to the United States. The country also recorded a higher consumption rate than the United States, with regard to the population versus unit consumption of clinical nutrition. Canada has a lower cost of clinical nutrition than that of the US, given its smaller population. It is a part of surgical procedures in Canada. More than 3% of the population turns 65 every year. The growing aging population and chronic illness conditions and the scope for clinical nutritional supplements are set to impact market growth. As of 2019, the annual per capita expenditure for dietary supplements in the country stood at $32.89. Such factors are set to put forth ample market growth opportunities in Canada.
Some of the qualified and well-established companies in the market are Exela Pharma Sciences, Lonza Ltd, Danone, Meiji Holdings Co Ltd, Grifols SA, etc.